 effect imazodan treatment chronic congest heart failur imazodan research group multicent double-blind placebo-control trial imazodan type iii phosphodiesteras inhibitor patient congest heart failur clinic efficaci safeti patient mg imazodan patient standard therapi diuret digoxin angiotensin-convert enzym inhibitor mean eject fraction exercis time baselin group signific differ placebo group treat group regard time eject fraction frequenc ventricular prematur complex ventricular tachycardia intent placebo mortal imazodan mortal signific studi imazodan benefit exercis perform placebo